149 related articles for article (PubMed ID: 30060818)
1. Neutral Sphingomyelinases in Cancer: Friend or Foe?
Clarke CJ
Adv Cancer Res; 2018; 140():97-119. PubMed ID: 30060818
[TBL] [Abstract][Full Text] [Related]
2. Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses.
Wu BX; Clarke CJ; Hannun YA
Neuromolecular Med; 2010 Dec; 12(4):320-30. PubMed ID: 20552297
[TBL] [Abstract][Full Text] [Related]
3. Neutral sphingomyelinases and nSMase2: bridging the gaps.
Clarke CJ; Hannun YA
Biochim Biophys Acta; 2006 Dec; 1758(12):1893-901. PubMed ID: 16938269
[TBL] [Abstract][Full Text] [Related]
4. Signalling sphingomyelinases: which, where, how and why?
Levade T; Jaffrézou JP
Biochim Biophys Acta; 1999 Apr; 1438(1):1-17. PubMed ID: 10216276
[TBL] [Abstract][Full Text] [Related]
5. Identification of Mg2+ -dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis.
Yabu T; Imamura S; Yamashita M; Okazaki T
J Biol Chem; 2008 Oct; 283(44):29971-82. PubMed ID: 18678863
[TBL] [Abstract][Full Text] [Related]
6. Altered sphingomyelinase and ceramide expression in the setting of ischemic and nephrotoxic acute renal failure.
Zager RA; Conrad S; Lochhead K; Sweeney EA; Igarashi Y; Burkhart KM
Kidney Int; 1998 Mar; 53(3):573-82. PubMed ID: 9507201
[TBL] [Abstract][Full Text] [Related]
7. Role of sphingomyelinases in neurological disorders.
Ong WY; Herr DR; Farooqui T; Ling EA; Farooqui AA
Expert Opin Ther Targets; 2015; 19(12):1725-42. PubMed ID: 26243307
[TBL] [Abstract][Full Text] [Related]
8. Ultraviolet B radiation induces activation of neutral and acidic sphingomyelinases and ceramide generation in cultured normal human keratinocytes.
Magnoni C; Euclidi E; Benassi L; Bertazzoni G; Cossarizza A; Seidenari S; Giannetti A
Toxicol In Vitro; 2002 Aug; 16(4):349-55. PubMed ID: 12110272
[TBL] [Abstract][Full Text] [Related]
9. The neutral sphingomyelinase family: identifying biochemical connections.
Clarke CJ; Wu BX; Hannun YA
Adv Enzyme Regul; 2011; 51(1):51-8. PubMed ID: 21035485
[TBL] [Abstract][Full Text] [Related]
10. The extended family of neutral sphingomyelinases.
Clarke CJ; Snook CF; Tani M; Matmati N; Marchesini N; Hannun YA
Biochemistry; 2006 Sep; 45(38):11247-56. PubMed ID: 16981685
[TBL] [Abstract][Full Text] [Related]
11. Targeting the ceramide system in cancer.
Henry B; Möller C; Dimanche-Boitrel MT; Gulbins E; Becker KA
Cancer Lett; 2013 May; 332(2):286-94. PubMed ID: 21862212
[TBL] [Abstract][Full Text] [Related]
12. The roles of neutral sphingomyelinases in neurological pathologies.
Horres CR; Hannun YA
Neurochem Res; 2012 Jun; 37(6):1137-49. PubMed ID: 22237969
[TBL] [Abstract][Full Text] [Related]
13. Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes.
Shamseddine AA; Airola MV; Hannun YA
Adv Biol Regul; 2015 Jan; 57():24-41. PubMed ID: 25465297
[TBL] [Abstract][Full Text] [Related]
14. Ceramide signalling and the immune response.
Ballou LR; Laulederkind SJ; Rosloniec EF; Raghow R
Biochim Biophys Acta; 1996 Jun; 1301(3):273-87. PubMed ID: 8664339
[TBL] [Abstract][Full Text] [Related]
15. Identification of neutral and acidic sphingomyelinases in Helicobacter pylori.
Lin YL; Liu JS; Chen KT; Chen CT; Chan EC
FEBS Lett; 1998 Feb; 423(2):249-53. PubMed ID: 9512367
[TBL] [Abstract][Full Text] [Related]
16. Bacterial infections and ceramide.
Grassmé H; Becker KA
Handb Exp Pharmacol; 2013; (216):305-20. PubMed ID: 23563663
[TBL] [Abstract][Full Text] [Related]
17. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling.
Wiegmann K; Schütze S; Machleidt T; Witte D; Krönke M
Cell; 1994 Sep; 78(6):1005-15. PubMed ID: 7923351
[TBL] [Abstract][Full Text] [Related]
18. Activation of acid sphingomyelinase by interleukin-1 (IL-1) requires the IL-1 receptor accessory protein.
Hofmeister R; Wiegmann K; Korherr C; Bernardo K; Krönke M; Falk W
J Biol Chem; 1997 Oct; 272(44):27730-6. PubMed ID: 9346915
[TBL] [Abstract][Full Text] [Related]
19. Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway.
Malaplate-Armand C; Florent-Béchard S; Youssef I; Koziel V; Sponne I; Kriem B; Leininger-Muller B; Olivier JL; Oster T; Pillot T
Neurobiol Dis; 2006 Jul; 23(1):178-89. PubMed ID: 16626961
[TBL] [Abstract][Full Text] [Related]
20. Neutral sphingomyelinase: past, present and future.
Chatterjee S
Chem Phys Lipids; 1999 Nov; 102(1-2):79-96. PubMed ID: 11001563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
